Sino Biopharmaceutical Ltd

01177: XHKG (HKG)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|H!LOCK|@rLOCK|?QLcjVV

Sino Biopharm Earnings: Raising Valuation by 12% on Earnings Beat, but Shares Still Expensive

Sino Biopharm's first-half revenue of CNY 17.6 billion grew 10.7% year over year, while net profit increased 101.1%.

Sponsor Center